17. Peritoneal epithelioid mesothelioma in a patient with metastatic melanoma - an association seen in BAP1 mutations

Annalisa Gatt; Oana Crainic; John F. Thompson; Richard A Scolyer; S. McCarthy; Ruta Gupta

doi:10.1097/01.pat.0000443707.58189.83

Related publications

Letter2012

Peritoneal melanosis associated with metastatic melanoma involving the omentum

Cathy Lim, John F. Thompson, Paul McKenzie, Stanley W. McCarthy, Richard A Scolyer

Article2017

SF3B1 and BAP1 mutations in blue nevus-like melanoma

Klaus Griewank, Hansgeorg Müller, Louise Jackett, Michael Emberger, Inga Möller, Johannes AP van de Nes, Lisa Zimmer, Elisabeth Livingstone, Thomas Wiesner, Simone L. Scholz, Ioana Cosgarea, Antje Sucker, Tobias Schimming, Uwe Hillen, Bastian Schilling, Annette Paschen, Henning Reis, Thomas Mentzel, Heinz Kutzner, Arno Rütten, Rajmohan Murali, Richard A Scolyer, Dirk Schadendorf

Article2020

We’ve never seen a patient with ARDS!

Jean Louis Vincent, Arthur S. Slutsky

Article2023

Long-Term Survival of More than 5 Years with Maintenance Therapy Using Single-Agent Pemetrexed in a Patient with Diffuse Malignant Peritoneal Mesothelioma

Yasuo Otsuka, Yoriaki Komeda, Masayuki Takeda, Takayuki Takahama, Masashi Kono, Mamoru Takenaka, Satoru Hagiwara, Naoshi Nishida, Hiroshi Kashida, Masatoshi Kudo

Article2022

Mutations in BAP1 drive tumour sensitivity to programmed cell death in patient-derived cholangiocarcinoma orgnaoids

Shaojun Shi, Imre F. Schene, Indi P. Joore, Henk P. Roest, Gilles van Tienderen, Ruby Lieshout, Bas Groot Koerkamp, Petra E. de Ruiter, Benedetta Artegiani, Sabine A. Fuchs, Hans Clevers, Luc J. W. van der Laan, Monique M.A. Verstegen